|1.||Velasco-Velázquez, Marco A: 2 articles (04/2010 - 01/2008)|
|2.||Salinas-Jazmín, Nohemí: 2 articles (04/2010 - 01/2008)|
|3.||Mendoza-Patiño, Nicandro: 2 articles (01/2008 - 08/2003)|
|4.||Yang, Xiao-hui: 1 article (04/2015)|
|5.||Li, Jing: 1 article (04/2015)|
|6.||Luo, Xiao-xing: 1 article (04/2015)|
|7.||Zhang, Zi-dan: 1 article (04/2015)|
|8.||Qu, Di: 1 article (04/2015)|
|9.||Wang, Yu-kun: 1 article (04/2015)|
|10.||Li, Zhou-peng: 1 article (04/2015)|
01/01/2011 - "We expect that an efficient linear synthesis of 4-hydroxycoumarin derivatives and key fragments that are useful agents for the modulation of inflammation as well as inhibition of coagulation will be of practical use."
07/01/2008 - "This effect was related to an improvement in the colonic oxidative status, since coumarin and 4-hydroxycoumarin prevented the glutathione depletion that occurred as a consequence of the colonic inflammation."
04/01/2008 - "Five new 4-hydroxycoumarin derivatives were tested for cytotoxic activity in two tumor cell lines--HL-60 and EJ. "
05/01/2014 - "In summary, this study has identified three novel coumarin derivatives that in comparison to 4-hydroxycoumarin have a higher efficiency to reduce cancer cell viability and trigger apoptosis and therefore may represent interesting novel drug candidates."
12/15/1986 - "Microsomes isolated from Lewis lung (LL) primary tumors raised in C57BL/6 mice have been shown to (i) contain a 4-hydroxycoumarin (warfarin)-sensitive cycle of vitamin K metabolism which is at least qualitatively similar to that of liver, and (ii) catalyze the incorporation of NaH14 CO3 into endogenous protein in a vitamin-K hydroquinone-dependent reaction to produce gamma-carboxyglutamate. "
|3.||Melanoma (Melanoma, Malignant)
08/20/2003 - "This study determined the in vitro effects of 4-hydroxycoumarin (4-HC) employing the melanoma cell line B16-F10 and the non-malignant fibroblastic cell line B82. "
04/01/2010 - "We have previously reported that in vitro treatment of B16-F10 melanoma cells with 4-hydroxycoumarin (4-HC) decreases their metastatic potential. "
04/01/2010 - "Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model."
01/01/2008 - "Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells."
08/20/2003 - "4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility."
|2.||Glutathione (Reduced Glutathione)
|6.||Acetic Acid (Vinegar)
|7.||Extracellular Matrix Proteins
|8.||1-Carboxyglutamic Acid (1 Carboxyglutamic Acid)